{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T20:02:13Z","timestamp":1771444933472,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,18]]},"DOI":"10.7759\/cureus.103853","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T19:07:04Z","timestamp":1771441624000},"source":"Crossref","is-referenced-by-count":0,"title":["Steroid-Resistant Immune Thrombocytopenia With Severe Bleeding Successfully Managed Using Eltrombopag and Mycophenolate in a 67-Year-Old Male"],"prefix":"10.7759","author":[{"given":"Abdul Hanan","family":"Farooq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Badar","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Muneer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Labiba","family":"Tasfia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S369574","article-title":"Older adults and immune thrombocytopenia: considerations for the clinician","volume":"18","author":"Crickx E","year":"2023","unstructured":"Crickx E, Mah\u00e9vas M, Michel M, Godeau B. Older adults and immune thrombocytopenia: considerations for the clinician. Clin Interv Aging. 2023, 18:115-30. 10.2147\/CIA.S369574","journal-title":"Clin Interv Aging"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2019.11.026","article-title":"Management of elderly patients with immune thrombocytopenia: real-world evidence from 451 patients older than 60\u00a0years","volume":"185","author":"Palandri F","year":"2020","unstructured":"Palandri F, Santoro C, Carpenedo M, et al.. Management of elderly patients with immune thrombocytopenia: real-world evidence from 451 patients older than 60\u00a0years. Thromb Res. 2020, 185:88-95. 10.1016\/j.thromres.2019.11.026","journal-title":"Thromb Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017634","article-title":"How I diagnose and treat thrombocytopenia in geriatric patients","volume":"143","author":"Foy P","year":"2024","unstructured":"Foy P, Friedman KD, Michaelis LC. How I diagnose and treat thrombocytopenia in geriatric patients. Blood. 2024, 143:214-23. 10.1182\/blood.2022017634","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019, 3:3829-66. 10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"ref5","article-title":"Real-world experience of eltrombopag in immune thrombocytopenia","volume":"10","author":"Mishra K","year":"2020","unstructured":"Mishra K, Pramanik S, Jandial A, et al.. Real-world experience of eltrombopag in immune thrombocytopenia. Am J Blood Res. 2020, 10:240-51.","journal-title":"Am J Blood Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05114-8","article-title":"Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus","volume":"102","author":"Pulani\u0107 D","year":"2023","unstructured":"Pulani\u0107 D, B\u00e1torov\u00e1 A, Bod\u00f3 I, et al.. Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus. Ann Hematol. 2023, 102:715-27. 10.1007\/s00277-023-05114-8","journal-title":"Ann Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21037\/aob-21-23","article-title":"The treatment of immune thrombocytopenia (ITP)\u2014focus on thrombopoietin receptor agonists","volume":"6","author":"Kuter DJ","year":"2021","unstructured":"Kuter DJ. The treatment of immune thrombocytopenia (ITP)\u2014focus on thrombopoietin receptor agonists. Annals of Blood. 2021, 6:10.21037\/aob-21-23","journal-title":"Annals of Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/448743-steroid-resistant-immune-thrombocytopenia-with-severe-bleeding-successfully-managed-using-eltrombopag-and-mycophenolate-in-a-67-year-old-male","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T19:07:05Z","timestamp":1771441625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/448743-steroid-resistant-immune-thrombocytopenia-with-severe-bleeding-successfully-managed-using-eltrombopag-and-mycophenolate-in-a-67-year-old-male"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.103853","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,18]]}}}